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Presentation by MHC molecules of peptides 
bearing  posttranslational  modifications  can 
elicit highly specific T cell responses, specu-
lated to be a component of autoimmunities. 
The T cells usually recognize the modified 
residue in the framework of the unmodified 
TCR contact residues of the peptide (Anderton, 
2004; Engelhard et al., 2006; Petersen et al., 
2009). One of the most compelling findings 
linking posttranslationally modified self-proteins 
to autoimmunity is the antibody response to 
citrullinated proteins in rheumatoid arthritis 
(RA). The presence of citrulline in proteins   
is  caused  by  the  enzymatic  deimination  of   
arginine residues; citrulline is not a natural 
amino acid encoded in DNA. The conver-
sion from peptidylarginine to peptidylcitrul-
line  is  catalyzed  by  the  peptidylarginine 
deiminase (PAD) family of enzymes, which 
differ in tissue expression. PAD2 and PAD4 
are both expressed by cells of the immune 
system. In RA, the antibodies are found early 
in disease, at levels that correlate with sever-
ity  (Klareskog  et  al.,  2008; Wegner  et  al., 
2010). Moreover, there is a strong correlation 
between antibody reactivity and the presence 
of RA-susceptible HLA alleles (de Vries et al., 
2006; van der Helm-van Mil and Huizinga, 
2008). Citrullinated peptides were shown to 
bind with higher affinity to the RA-susceptible 
HLA allele DR4 as a result of the more favor-
able interaction of the citrulline side chain 
with the positively charged P4 pocket (Hill 
et al., 2003).
We previously reported that immuniza-
tion with the protein hen egg-white lysozyme 
(HEL)  gave  rise  to T  cells  that  recognized 
different  sets  of  HEL  peptides  presented   
by class II MHC molecules (Ireland et al.,   
2006). In this study, we correlate the response 
of  a T  cell  that  exclusively  recognizes  the   
chemically  dominant  HEL  peptide,  48–62 
(DGSTDYGILQINSRW),  with  a  citrulline   
to arginine change at residue 61 (48–62-Cit61)   
to autophagy.
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Antibody responses to citrullinated self-proteins are found in autoimmunities, particularly 
in rheumatoid arthritis, where they serve as a diagnostic indicator. We show here that 
processing of the protein hen egg-white lysozyme (HEL) resulted in citrullination of pep-
tides presented on class II MHC molecules by antigen-presenting cells. The presentation of 
the citrullinated peptides but not of the unmodified peptides was associated with autoph-
agy. Dendritic cells (DCs), macrophages, and thymic DCs presented citrullinated peptides 
constitutively. Their treatment with 3-methyladenine (3MA) blocked presentation of 
citrullinated HEL peptides, but presentation of unmodified peptides was not affected. 
Presentation of citrullinated peptides was not detected on B cells or B lymphoma cells 
under normal culture conditions. In B cells, engagement of the B cell antigen receptor was 
required for presentation of the citrullinated peptides, also inhibited by 3MA. B lymphoma–
expressing HEL cells presented citrullinated peptides only after brief serum starvation. This 
presentation was reduced by 3MA or by reduction in Atg5 expression. Presentation of the 
unmodified peptides was not changed. The findings indicate a linkage between autophagy 
and autoreactivity through the generation of this neo-epitope.
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months it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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In contrast, splenic CD19+ cells did not elicit a response from 
the 48–62-Cit61–reactive hybridoma, though the response of 
3A9 was strong (Fig. 1, E and F). Thus, although DCs and macro-
phages presented the citrullinated derivative from HEL, B cells 
only presented the unmodified epitope. This finding is in con-
cordance with our previously published results demonstrating 
that a B cell lymphoma did not present citrullinated peptides 
after processing HEL (Ireland et al., 2006). Lastly, we verified 
the presentation of citrullinated peptides by APCs in the drain-
ing lymph nodes of B10.BR mice immunized with 10 nmol 
HEL in adjuvant (Fig. 1, G and H).
Serum starvation induces presentation of citrullinated 
peptides by B lymphoma cells
To determine the reasons for the lack of citrullination by   
B cells and explore conditions that may induce it, we exam-
ined C3.F6, a B lymphoma line which when cultured with 
HEL does not present the 48–62-Cit61 peptide (Ireland et al., 
2006). We examined in particular C3.F6.mHEL that expresses 
HEL with a transmembrane linker and constitutively presents 
high levels of HEL peptides on I-Ak molecules. There was strik-
ing presentation of HEL 48–62-Cit61 if the cells were cul-
tured without FCS for a limited period of time, as little as 3–4 h 
(Fig. 2 A). The response to the unmodified 48–62 was not 
changed by C3.F6.mHEL cultured in reduced FCS (Fig. 2 C). 
Moreover, total citrullinated peptides were detected by bio-
chemical approaches in eluates from I-Ak molecules isolated 
from C3.F6.mHEL. The mean percent increase in citrulli-
nated peptides was 580% in cells cultured in 1% FCS com-
pared with those cultured in 5% (n = 4 experiments; Table S1).
We considered whether the B cell line was undergoing 
autophagy as a result of the stress imposed by lowering the 
FCS  concentration.  Several  studies  indicated  that  APCs 
constitutively underwent autophagy and that this process 
contributed to the repertoire of peptides presented on MHC 
class II molecules (Nimmerjahn et al., 2003; Dengjel et al., 
2005;  Dörfel  et  al.,  2005;  Paludan  et  al.,  2005;  Schmid   
et al., 2007). The serum-starved cells were treated with   
3-methyladenine (3MA), a class III PI3 kinase inhibitor, 
during the period of serum starvation. 3MA inhibits au-
tophagy (Seglen and Gordon, 1982; Petiot et al., 2000), al-
though effects on other components of intracellular protein 
processing and or catabolism were not ruled out. After cul-
ture with HEL, the presentation of HEL 48–62-Cit61 by 
the serum-starved cell line was entirely reduced by treat-
ment with 3MA (Fig. 2 A). In striking contrast, the T cell 
response to the unmodified 48–62 peptide was not affected 
at all (Fig. 2 C). There was no difference in responses among 
untreated, serum-starved cells, or serum-starved cells treated 
with 3MA when cultured just with the HEL 48–62-Cit61 
peptide, where processing is not required, indicating that 
their levels of MHC molecules were not altered (Fig. 2 B). 
C3.F6.mHEL cultured without FCS had an increase in the 
levels of LC3II, which was reduced by 3MA treatment, con-
firming induction of autophagy by serum starvation and its 
inhibition by 3MA (Fig. 2 D).
RESULTS AND DISCUSSION
Primary APCs present citrullinated peptides in vivo
To determine whether presentation of citrullinated peptides by 
class II MHC molecules occurred normally from in vivo APCs 
presenting a self-protein, membrane HEL (mHEL) transgenic 
mice were examined. All APCs from these mice expressed HEL 
linked to the transmembrane region of Ld under the I-E pro-
moter. Presentation of HEL 48–62 by APCs isolated from these 
mice  was  strong,  found  to  be  3,400–20,000  peptide–MHC 
complexes per cell (Peterson et al., 1999). DCs identified as 
CD11c+ cells from the thymi and spleens of mHEL mice elicited 
a robust response to the dominant HEL peptide 48–62 (using as 
indicator cell the CD4 T cell hybridoma 3A9, which recog-
nized the unmodified peptide; Fig. 1, B and D). The APCs 
also presented 48–62-Cit61 (using Granny as the indicator T cell 
that only recognized the citrullinated peptide; Fig. 1, A and C). 
Figure 1.  Presentation of citrullinated peptides by freshly harvested 
APCs. (A–F) IL-2 production from CD11c+ cells isolated from thymi  
(A and B), spleen (C and D), and splenic CD19 + cells (E and F). A, C, and E 
show response to the 48–62-Cit61 peptide by Granny, whereas B, D, and F 
show response to the unmodified 48–62 by 3A9. (G and H) The response to 
CD11c+, CD11b+ cells purified from the popliteal lymph nodes of mice 24 h 
after immunization with 10 nmol HEL and tested against (G) Granny or  
(H) 3A9 is shown. Data from each panel are representative of at least two 
independent experiments, and each data point represents duplicate wells. 
At least three mice were used in each experiment. Error bars indicate SEM.JEM Vol. 208, No. 13  2627
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flow cytometry. As a negative control, cells were infected with 
virus containing shRNA that targeted Luciferase expression. 
The shRNA system effectively reduced Atg5 expression by 
Western blot (Fig. 2 I). RT-PCR indicated a 72% decrease 
in Atg5 message relative to Luciferase knockdown controls 
(not depicted). The cells exhibited reduced levels of LC3II 
conversion (Fig. 2 I). There was no difference in the levels of 
messenger RNA (mRNA) to PAD2 or PAD4 (Fig. S1 C). 
Inhibition of Atg5 expression in serum-starved cells resulted in 
no presentation of citrullinated peptides from HEL (Fig. 2 E). 
Low expression of Atg5 inhibits presentation after serum 
starvation of B lymphoma cells
We next assessed an alternative method for inhibiting au-
tophagy. We designed short hairpin RNA (shRNA) con-
structs that targeted expression of Atg5, a protein essential for 
autophagy, and cloned them into a lentiviral delivery system 
in which the infected cells expressing YFP were purified by 
Figure 2.  C3.F6.mHEL cells present citrullinated peptides after 
serum starvation–induced autophagy. (A–C) T cell responses to C3.F6.
mHEL cultured in DME supplemented with 5% FCS (D5F), no serum (DOF), 
or no serum in the presence of 10 mM 3MA (D0F 3MA) for 4 h; the cul-
ture medium was then changed to 5% FCS, and the T cell hybridomas 
Granny (A and B) or 3A9 (C) were added. (D) Western blot of actin and 
LC3II in C3.F6.mHEL cultured in D10F, D0F, and D0F with 3MA. Data are 
representative of three independent experiments; each data point repre-
sents duplicate wells. Targeted knockdown of Atg5 expression inhibited 
citrullination of HEL peptides. (E–H) Responses of T cells to C3.F6.mHEL 
cells expressing either shRNA targeting Atg5 expression (E and G) or lucif-
erase expression (F and H). Cells were cultured in media supplemented 
with 5% FCS, 0.5% FCS, or no FCS for 4 h and then replaced with media 
supplemented with 5% FCS. (I) Western blot of actin, Atg5 levels, and 
LC3II in the treated C3.F6.mHEL cells shows that Atg5-deficient cells had 
reduced levels of LC3II conversion after serum starvation. Data are repre-
sentative of three independent experiments. Error bars indicate SEM.
Figure 3.  PAD expression in APCs alone is not sufficient for citrul-
lination of HEL; PAD activity can be detected in autophagosomes.  
(A and B) PAD2 (A) and PAD4 (B) mRNA was measured by RT-PCR and quan-
tified using DNA standards. Data are presented as the mean of quadruplicate 
reaction replicates and are representative of at least two independent experi-
ments. (C) PAD activity was measured biochemically in lysates of C3.F6.P4 
cells after the addition of tetracycline. Data are the mean of triplicate reac-
tions and are representative of three independent experiments. (D) Presenta-
tion of HEL or HEL peptide to Granny by C3.F6.P4 with or without tetracycline 
to induce PAD4 expression in normal culture conditions or after culture in 
DME without FCS (SS in the panel). Data are representative of three indepen-
dent experiments. (E) PAD activity as measured by conversion of an artificial 
substrate was assessed in fractions of elicited PECs. The fractions are repre-
sented with numbers as follows: 1, whole cell lysate; 2, postnuclear superna-
tant; 3, nuclei; 4, second pellet enriched in mitochondria and peroxisomes;  
5, light membrane fraction; 6, complex heavy fraction enriched in the ER; and 
7, final autophagosome pellet. The negative control (Neg) contained substrate 
without protein. The data presented are pooled from three independent ex-
periments. 20–60 mice were used in each experiment. (F) The fractions were 
analyzed by Western blot for LC3II enrichment. The data are representative 
three independent experiments. Error bars indicate SEM.2628 Presentation of citrullinated peptides to T cells | Ireland and Unanue
promoter with tetracycline operon regulatory elements; such 
a vector was cotransfected with the tetracycline repressor. 
We verified that treatment of C3.F6.P4 with tetracycline 
led to expression of biologically active PAD4 by measuring 
PAD activity in cell lysates (Fig. 3 C). However, cells ex-
pressing PAD4 did not present 48–62-Cit61 peptide from HEL 
unless they were cultured in serum-free conditions (Fig. 3 D), 
indicating that PAD4 expression alone was not sufficient to 
allow citrullination of antigen and that other factors were 
playing a role. In support of this conclusion, we found that 
conditions that led to induced citrullination of HEL were 
not associated with changes in expression of either PAD2 or 
PAD4 (Fig. S1).
The results indicated that autophagy was involved, i.e., 
induced presentation after serum starvation and its inhibition 
by 3MA or by reduced Atg5 expression. However, the data 
also indicated that PAD expression alone was not the sole limit-
ing factor for citrullination of antigen and raised the question 
of whether PAD enzymes gained access to antigen-loading 
compartments through the autophagic pathway. That the con-
tents of autophagosomes contributed to antigen-processing 
compartments has been well documented. In addition, it has 
been shown that calcium, which was 
required  for  PAD  activity,  accumu-
lated in autophagic vesicles (Fader et al., 
2008).  To  address  this  question,  we 
examined  PECs  that  presented  well 
the Cit61 epitope from HEL (Fig. 4, 
B and F). The PECs were fraction-
ated,  and  the  purified  autophagic   
vesicles were tested for PAD enzy-
matic activity and LC3II (Seglen and 
Brinchmann,  2010).  All  the  various 
fractions showed PAD activity, as ex-
pected from its known distribution in 
various  cell  compartments.  Impor-
tantly the autophagosomes contained 
PAD activity and were enriched for 
LC3II (Fig. 3, E and F).
In contrast, there was presentation of citrullinated peptides in 
the control cells in which luciferase expression was targeted 
(Fig. 2 F). Neither serum starvation nor expression of Atg5 
had any bearing on presentation of the unmodified epitope, 
HEL 48–62 (Fig. 2 G).
PAD2 and PAD4 expression alone is not sufficient  
for citrullination of antigen, and PAD activity  
can be detected in isolated autophagosomes
Whether the poor presentation by B cells and B lymphoma 
cells could be attributed to an absence or poor expression of 
the enzymes that convert arginine to citrulline was a concern. 
PAD2 and PAD4 are expressed in APCs, but PAD4 was 
shown to be expressed at lower levels in C3.F6 and B cells 
(Vossenaar et al., 2004; Ireland et al., 2006). Quantitation of 
PAD2 and PAD4 mRNA in the various APCs examined   
in this study confirmed these findings (Fig. 3, A and B).   
Although peritoneal exudate macrophages (PECs) and DCs 
expressed both enzymes, PAD4 expression was weakly de-
tected in C3.F6. We generated a C3.F6 line in which expres-
sion of PAD4 was induced (C3.F6.P4). PAD4 was cloned 
from splenic APCs into a vector under control of the CMV 
Figure 4.  Treatment with 3MA inhibits 
presentation of citrullinated peptides by 
DCs or PECs. (A and B) Presentation of HEL  
to Granny (left panel labeled 48-62Cit61) or 
3A9 (right panel labeled 48–62) with and 
without 10 mM 3MA to DCs (A) or PECs (B).  
(C and D) Presentation of the synthetic peptide 
with and without 3MA to DCs (C) or PECs (D). 
(E–H) Presentation of 30 µM HEL or 3 µM of 
the synthetic peptide to DCs (E and G) or PECs 
(F and H) examining different concentrations 
of 3MA. (I and J) Presentation of citrullinated 
peptide was examined after a 1-h culture in 
Krebs-Ringer bicarbonate buffer (KRB) after a 
short 2-h pulse with HEL in DCs (I) or PECs (J). 
Data are representative of two to three ex-
periments. Error bars indicate SEM.JEM Vol. 208, No. 13  2629
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extent in PECs (Fig. 4 J) when pulsed for 2 h with HEL and 
then cultured for 1 h in either DME or Krebs-Ringer bicar-
bonate buffer.
B cells present citrullinated peptides after engagement  
of their antigen receptor
The conditions that might induce citrullination by primary   
B cells were evaluated using B cells from mHEL mice or mono-
clonal B cells from anti-HEL transgenic mice. LPS did not 
result in presentation of the 48–62-Cit61 epitope; culturing 
in starvation media resulted in poor survival and uninter-
pretable results. However, addition of anti-IgM antibodies 
Presentation of citrullinated peptide by primary APCs  
is inhibited by 3MA and enhanced by amino acid starvation
These findings relating autophagy to the presentation of the 
citrullinated peptides were then applied to presentation by 
DCs, PECs, and primary B cells. The citrullinated peptides 
were presented by either DCs (Fig. 4, A and E) or PECs (Fig. 4, 
B and F) after processing HEL. The addition of 3MA inhib-
ited presentation in a dose-dependent manner. In contrast, 
presentation of HEL to 3A9 or presentation of synthetic 
peptide was not affected at all over a range of 3MA concen-
trations in either cell type (Fig. 4, C, D, G, and H). We did ob-
serve enhanced presentation in DCs (Fig. 4 I) and to a lesser 
Figure 5.  BCR engagement induces presentation of citrullinated peptides by primary B cells. (A and B) Presentation by CD19+ cells isolated from spleens 
of mHEL mice. (A) Effects of various concentrations of anti-IgM or anti-Ig on Granny ± 3MA. (B) The same as in A but on 3A9 ± 3MA. (C) Presentation of HEL by 
CD19+ cells from anti-HEL transgenic mice or B10.BR mice to Granny. (D) The same as in C but to 3A9. (E) The effect of 3MA on presentation by CD19+ cells from 
anti-HEL transgenic mice after processing HEL to Granny. (F) The same as in E but to 3A9. (G) Presentation of HEL by B cells from B10.BR mice to Granny after 
treatment with 40 µg/ml anti-IgM ± 3MA. (H) The same as in G but treating the cells with anti-IgG ± 3MA. (I and J) Western blots of actin and LC3II from mHEL  
B cells cultured overnight with anti-Ig (I) or anti-HEL B cells cultured with 30 µM HEL ± 3MA (J). (K) B cells from GFP-LC3 mice were labeled on ice with anti-IgM 
and fixed immediately or after 1 h at 37°C and stained to label MHC class II. All data are representative of at least two independent experiments.2630 Presentation of citrullinated peptides to T cells | Ireland and Unanue
poor, requiring the stress signal of low serum to induce citrul-
lination. In primary B cells, the effectiveness of capping surface 
Ig in inducing presentation of the citrullinated epitope was 
striking. These findings point to the intracellular events that 
bring the PAD molecule into the autophagic vesicles of the 
APCs as fundamental to whether or not citrullination of anti-
gen takes place.
The connection between citrullination and autophagy in 
APCs raises several issues. One is the teleological explanation 
for the citrullination of proteins. Citrullination alters intra-
molecular interactions and can lead to increased accessibility 
to proteolysis (Tarcsa et al., 1996; Pritzker et al., 2000). In 
addition, the change from arginine to citrulline may expand 
the repertoire of presented peptides (Hill et al., 2003; de Haan 
et al., 2005; Ireland et al., 2006; Beltrami et al., 2008).   
Finally, the finding that an antibody to the B cell antigen re-
ceptor can drive the presentation of citrullinated epitopes is 
particularly of note in the context of RA, with its component 
of autoantibodies to Ig, such as rheumatoid factor. The com-
bination of anti-Ig autoantibodies, autophagy-inducing events, 
and the appropriate class II HLA alleles may contribute to 
presentation of citrullinated self-peptides and a breach of 
immunological tolerance, precipitating events that lead to the 
initiation and/or progression of an autoimmune process.
MATERIALS AND METHODS
Cell culture. CD4 T cell hybridomas were made by fusing cells obtained 
from popliteal lymph nodes 7 d after immunization with 10 nmol HEL in 
complete Freund’s adjuvant and fusing to the BW5147--thymoma cells 
line, as previously described (Peterson et al., 1999). C3.F6.mHEL B lym-
phoma cells were used as APCs for examining the response to the various 
peptides. PECs were obtained by intraperitoneal injection with 1 ml thiogly-
collate or 100 mg concanavalin A. After 4 d, PECs were harvested. DCs 
were derived from bone marrow cultured for 8 d in GM-CSF–containing 
medium. Bone marrow was plated at 3.3 × 105 cells per well in a 6-well plate 
in DME supplemented with conditioned culture supernatant. The media 
was changed on day 4. Hybridoma activation was measured by IL-2 secre-
tion as assayed by proliferation of the IL-2–dependent line CTLL. Where 
indicated, cells were purified using the Miltenyi magnetic cell separation re-
agents and LS columns (Miltenyi Biotec).
Mice and reagents. B10.BR mice usually 6–12 wk old of both sexes were 
obtained from the Jackson Laboratory and maintained in facilities under specific 
pathogen–free conditions at Washington University in St. Louis (St. Louis, MO) 
in accordance with institutional animal care guidelines. Animal protocols were 
approved by the Washington University Animal Studies Committee. B10.
BR mice expressing mHEL under the class II E promoter were generated 
and maintained by our laboratory (Peterson et al., 1999). GFP-LC3 mice 
were a gift from K. Boehle in the laboratory of K. Moley at Washington 
University in St. Louis. HEL was obtained from Sigma-Aldrich and purified to 
eliminate contaminant proteins and LPS. Dylight 567–labeled rabbit anti-
IgM, rabbit anti-IgG, rabbit anti-IgM, and rabbit anti-IgM F(ab)2 were ob-
tained from Jackson ImmunoResearch Laboratories, Inc. Biotinylated anti–I-Ab 
was obtained from BD. Streptavidin-conjugated Alexa Fluor 647 was pur-
chased from Invitrogen. Peptides were synthesized using Fmoc techniques. 
3MA was obtained from Sigma-Aldrich and suspended at 100 mM in saline 
and before use heated at 56°C until dissolved and then used immediately.
Western blot. 100 µM chloroquine was added to the media during the 
final 15 min of culture. Cells were washed in serum-free media and lysed for 
10 min on ice in lysis buffer (50 µM Tris-HCl, pH 8.0, 150 mM NaCl, 
induced strong presentation of the 48–62-Cit61 epitope from 
B cells of mHEL mice (Fig. 5 A). Identical results were found 
adding F(ab)2 fragments of the antibody. Treatment of B cells 
with anti-IgG also induced a level of presentation of citrulli-
nated  peptides.  Fig.  5 A  also  shows  that  presentation  of 
citrullinated peptides by both anti-IgM and anti-IgG was 
inhibited by treatment with 3MA, again pointing to an au-
tophagy response. 3MA did not inhibit the presentation of 
the unmodified 48–62 peptide to 3A9 by the B cells from 
mHEL mice (Fig. 5 B). There was an increase in LC3II levels 
in B cells treated with either anti-IgM or anti-IgG (Fig. 5 I), 
consistent with a report that BCR engagement induces au-
tophagy in B cells (Watanabe and Tsubata, 2009).
Likewise, B cells from anti-HEL B cell transgenic mice 
presented the HEL 48–62-Cit61 epitope after taking up and 
processing HEL (Fig. 5 C). Such presentation was inhibited by 
3MA (Fig. 5 E). In contrast, B cells from B10.BR mice, even 
with high concentrations of HEL, up to 100 µM HEL, did not 
present it. However, we observed enhanced presentation of 
citrullinated peptides from processed HEL in the presence of 
anti-IgM (Fig. 5 G) or anti-IgG (Fig. 5 H) by B cells from B10.
BR mice, which was similarly inhibited by 3MA. In contrast 
to DCs and macrophages, in which 3MA has no effect on pre-
sentation of 48–62, we observed some effect in B cells present-
ing HEL to 3A9 (Fig. 5 F). It appears that autophagy, although 
not  required  for  presentation  of  unmodified  peptide,  may 
make some contribution to processing or presentation of HEL 
by B cells. We found that anti-HEL B cells but not B10.BR 
B cells cultured with HEL had increased LC3II levels, which 
was inhibited by 3MA (Fig. 5 J).
To examine the intracellular events occurring after BCR 
engagement, we examined B cells from GFP-LC3 mice that 
express a GFP-LC3 fusion protein as a marker of autophago-
somes (Mizushima and Kuma, 2008). As expected, treatment 
with anti-IgM led to capping and internalization of surface 
IgM (Fig. 5 K). After treatment with anti-IgM, GFP-positive 
vesicles were observed that colocalized with MHC II vesicles 
and internalized IgM, thereby demonstrating an association 
of autophagic vesicles with BCR-mediated uptake and pro-
cessing for presentation on MHC II.
In summary, we presented evidence that autophagy was a 
key cellular event involved in the generation of citrullinated 
peptides by APCs. Our findings posit that presentation of 
citrullinated peptide is a result and a biochemical marker of 
an autophagy response. The inhibition by 3MA of presenta-
tion of HEL peptides in DCs and PECs was highly selective, 
only affecting that of the 48–62-Cit61 epitope. The findings 
argue for distinct sites in the APCs where each processing 
event takes place, i.e., the one that generates the 48–62-Cit61 
peptide and the one that gives rise to the unmodified 48–62 
peptides. The effective presentation of the citrullinated epitopes 
by DCs and macrophages compared with the very weak 
presentation by primary B cells or B cell lines could have 
several explanations. The levels of PAD4 were very low in   
B cells. A second component became evident in the C3.F6 line 
made to overexpress PAD4 in which again presentation was JEM Vol. 208, No. 13  2631
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5 M HClO4 to one fifth of the total volume. Citrulline was measured using 
methods described previously using free citrulline as a standard (Holm   
et al., 2006).
Microscopy. Fixed cells were permeabilized with Perm/Wash buffer (BD) 
and treated with 10% 24G2 supernatant to block Fc receptors. Cells were 
stained in solution on ice and cytospun onto glass slides for imaging. Cells 
were mounted with ProLong gold (Invitrogen). Cells were imaged with a 
laser-scanning confocal microscope (510; Carl Zeiss).
Quantitation of citrulline in naturally processed peptides. C3.F6 mHEL 
were cultured in 2L roller bottles in DME supplemented with either 5 or 1% 
FCS and cultured at 37°C until they reached confluence. Naturally processed 
peptides were purified as previously described using 40F anti–I-Ak antibody–
conjugated Sepharose (Suri et al., 2002). Citrulline was measured using methods 
described previously using free citrulline as a standard (Holm et al., 2006).
shRNA targeting. Stable cell lines expressing shRNA designed to target ex-
pression of Luciferase as a control or Atg5 were generated with the previously 
described pFLRU lentiviral vector system (Langer et al., 2008). The pFLRU:
shRNA:Luciferase and packaging vectors were a gift from J. Bednarski in the 
laboratory of B. Sleckman at Washington University in St. Louis. The primers 
used to make the Atg5-targeting vectors were 5-GTGGAAAGGACGAAA-
CACCGGAAGAACTTAGCCTATATTTCAAGAGAATATAGG-3 
and 5-TCCAGCTCGAGAAAAAGGAAGAACTTAGCCTATATTCT-
CTTGAAATATAGG-3 (bold portions indicate the specific targeting sequence 
for ATG5 knockdown, and the remainder of the sequences is for construction of 
the hairpin loop and the expression cassette). 2 µg of the pFLRU vectors was co-
transfected with 1.6 µg pHR8.2R packaging vector and 0.4 µg pCMV-VSVg 
envelope plasmid into HEK293T cells with Lipofectamine 2000 (Invitrogen). 
Supernatants were harvested 24 h later, and after centrifuging three times for 
5 min at 500 g to remove any HEK293T cells, supernatants were transferred 
to C3.F6.mHEL cells with Polybrene added to 5 µg/ml. After 24 h, cells were 
placed under puromycin selection, and after two passages, cells expressing high 
YFP were purified by flow cytometric cell sorting.
Online supplemental material. Fig. S1 shows PAD2 and PAD4 expres-
sion in APCs under the experimental conditions included in this study. Table S1   
includes a summary of four independent experiments that examined the 
level of citrulline in naturally processed peptides from cells cultured under   
normal conditions compared with those cultured in serum-starved conditions.   
Online supplemental material is available at http://www.jem.org/cgi/ 
content/full/jem.20110640/DC1.
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